Stockholders' Equity Attributable to Parent in USD of Roivant Sciences Ltd. from Q1 2021 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.
Summary
Roivant Sciences Ltd. quarterly Stockholders' Equity Attributable to Parent history and change rate from Q1 2021 to Q3 2025.
  • Roivant Sciences Ltd. Stockholders' Equity Attributable to Parent for the quarter ending 30 Sep 2025 was $4.36B, a 15.3% decline year-over-year.
Stockholders' Equity Attributable to Parent, Quarterly (USD)
Stockholders' Equity Attributable to Parent, YoY Quarterly Change (%)

Roivant Sciences Ltd. Quarterly Stockholders' Equity Attributable to Parent (USD)

Period Value YoY Chg Change % Date Report Filed
Q3 2025 $4.36B -$791M -15.3% 30 Sep 2025 10-Q 10 Nov 2025
Q2 2025 $4.35B -$1.09B -20% 30 Jun 2025 10-Q 11 Aug 2025
Q1 2025 $4.69B -$1.28B -21.5% 31 Mar 2025 10-Q 10 Nov 2025
Q4 2024 $5.19B -$900M -14.8% 31 Dec 2024 10-Q 10 Feb 2025
Q3 2024 $5.15B +$4.2B +443% 30 Sep 2024 10-Q 12 Nov 2024
Q2 2024 $5.44B +$4.52B +497% 30 Jun 2024 10-Q 09 Aug 2024
Q1 2024 $5.97B +$4.81B +416% 31 Mar 2024 10-K 29 May 2025
Q4 2023 $6.09B +$5.13B +537% 31 Dec 2023 10-Q 13 Feb 2024
Q3 2023 $949M -$212M -18.3% 30 Sep 2023 10-Q 13 Nov 2023
Q2 2023 $911M -$473M -34.2% 30 Jun 2023 10-Q 14 Aug 2023
Q1 2023 $1.16B -$499M -30.1% 31 Mar 2023 10-K 30 May 2024
Q4 2022 $956M -$910M -48.8% 31 Dec 2022 10-Q 13 Feb 2023
Q3 2022 $1.16B -$877M -43.1% 30 Sep 2022 10-Q 14 Nov 2022
Q2 2022 $1.38B -$339M -19.7% 30 Jun 2022 10-Q 15 Aug 2022
Q1 2022 $1.66B -$141M -7.83% 31 Mar 2022 10-K 28 Jun 2023
Q4 2021 $1.87B 31 Dec 2021 10-Q 14 Feb 2022
Q3 2021 $2.04B 30 Sep 2021 10-Q 15 Nov 2021
Q2 2021 $1.72B 30 Jun 2021 10-Q 21 Sep 2021
Q1 2021 $1.8B 31 Mar 2021 10-K 28 Jun 2022
* An asterisk sign (*) next to the value indicates that the value is likely invalid.